Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $30.63 million. The enterprise value is $23.68 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 60.06 million shares outstanding. The number of shares has increased by 66.92% in one year.
| Current Share Class | 60.06M |
| Shares Outstanding | 60.06M |
| Shares Change (YoY) | +66.92% |
| Shares Change (QoQ) | +128.12% |
| Owned by Insiders (%) | 4.24% |
| Owned by Institutions (%) | 6.99% |
| Float | 54.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.47 |
| P/TBV Ratio | 4.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.60 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -234.70% and return on invested capital (ROIC) is -146.57%.
| Return on Equity (ROE) | -234.70% |
| Return on Assets (ROA) | -101.66% |
| Return on Invested Capital (ROIC) | -146.57% |
| Return on Capital Employed (ROCE) | -164.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.68M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.97% in the last 52 weeks. The beta is 4.24, so INTS's price volatility has been higher than the market average.
| Beta (5Y) | 4.24 |
| 52-Week Price Change | -80.97% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.73 |
| Relative Strength Index (RSI) | 56.94 |
| Average Volume (20 Days) | 4,125,087 |
Short Selling Information
The latest short interest is 3.59 million, so 5.97% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 16.77M |
| Short % of Shares Out | 5.97% |
| Short % of Float | 6.55% |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.04M |
| Pretax Income | -11.74M |
| Net Income | -11.74M |
| EBITDA | n/a |
| EBIT | -12.04M |
| Earnings Per Share (EPS) | -$0.51 |
Full Income StatementBalance Sheet
The company has $7.07 million in cash and $118,000 in debt, giving a net cash position of $6.95 million or $0.12 per share.
| Cash & Cash Equivalents | 7.07M |
| Total Debt | 118,000 |
| Net Cash | 6.95M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 7.22M |
| Book Value Per Share | 0.15 |
| Working Capital | 5.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |